Aqtual, Inc.

To continue the series of highlighting the "Aqtual" voices of our team members, we asked our VP of Data Integrity & GxP Systems, Jason Carlson what motivates him to contribute to Aqtual's mission every day.

Wishing you a bright and cheerful holiday season from all of us at Aqtual!

We’re thrilled to be featured in the Rheumatologist, as part of the American College of Rheumatology’s roundup of top research in rheumatoid arthritis from #ACR24! It’s an honor to stand alongside other groundbreaking studies driving innovation in RA care. Our inclusion underscores the potential of using our novel active chromatin cell-free DNA platform to predict treatment response in RA through a simple blood test, eliminating the need for invasive tissue sampling. We’re proud to play a role in advancing precision medicine in rheumatology. Check out the full list of standout research here:  https://lnkd.in/e9Sc7vPy

What an exciting weekend at #ACR24 in Washington, DC! We’re thrilled to share that our poster was selected for the prestigious ACR Poster Tour—a proud moment for Aqtual. Our VP of Translational Research, Maggie Louie, had the honor of presenting our groundbreaking work to fellow colleagues in the rheumatology field. Learn more about our data presentations and how they align with our mission to launch the first RA therapy selection test in 2025—offering a positive prediction of drug-class-specific therapy response for patients: https://lnkd.in/eeDiCnfS

What an exciting weekend at #ACR24 in Washington, DC! We’re thrilled to share that our poster was selected for the prestigious ACR Poster Tour—a proud moment for Aqtual. Our VP of Translational Research, Maggie Louie, had the honor of presenting our groundbreaking work to fellow colleagues in the rheumatology field. Learn more about our data presentations and how they align with our mission to launch the first RA therapy selection test in 2025—offering a positive prediction of drug-class-specific therapy response for patients: https://lnkd.in/eeDiCnfS

Headed to ACR Convergence 2024 (American College of Rheumatology) this weekend? Be sure to stop by booth 2405-G, and check out our presentation of new data supporting our innovative blood-based test for rheumatoid arthritis therapy selection. See you there! #ACR24 #Rheumatology Signe Fransen , Brad Hoolahan, Maggie Louie, David Lo, Carleen Tabari, Diana Abdueva

At Aqtual, we know that the quiet wisdom and occasional mischief of our cats add a unique spark to our workdays. These whiskered colleagues might not make it into our meetings (or sometimes they do!), but their companionship and antics bring us joy and balance during busy days. Introducing the highly requested Cats of Aqtual! From playful kittens to wise old souls, here are the felines that make each day just a little brighter. Do you have a furry friend who brings joy to your workday? Share a photo with us below! #PrecisionMedicine #Aqtual

In a new series, we will be highlighting the “Aqtual” voices of our team members - we seek to share their proudest moments, greatest wins, and biggest learnings. To kick things off, we asked our CEO and Founder, Diana Abdueva what her proudest moment has been since our founding. Leading the charge, Diana has guided Aqtual from groundbreaking science to the brink of launching our first product—a milestone that epitomizes our commitment to transforming healthcare. Stay tuned for more insights from the dedicated voices behind Aqtual. #PrecisionMedicine #AqtualVoices

At Aqtual, we know that great work happens with a little support from our four-legged friends. Whether they are by our side through virtual meetings, or boosting morale during deadlines, our furry friends remind us of the importance slowing down and enjoying the little things in life with tail-wagging enthusiasm. 🐕🦺 From playful pups to wise seniors, here's a look at the beloved dogs that bring a little extra happiness to our days! #PrecisionMedicine #Aqtual

Aqtual is attending the Congress of Clinical Rheumatology (CCR) West this week! Attending the conference and interested in learning more about our PRIMA-102 study and RA Therapy Selection Test we are developing? Be sure to reach out to Brad Hoolahan to set up some time to chat! #CCRWest #Rheumatology https://lnkd.in/eJVkAufN